https://www.selleckchem.com/pr....oducts/ac-fltd-cmk.h
potent anticoagulants in the total population or at lower volume hospitals. This study provides further support for aspirin as an effective form of pharmacological VTE prophylaxis after total joint arthroplasty in the setting of a multi-modal regimen using 30-day outcomes. VTE occurred in 0.7% of primary joint arthroplasties. Aspirin prophylaxis did not associate with greater VTE risk compared to potent anticoagulants in the total population or at lower volume hospitals.Robot-assisted arthroplasty is likely to grow exponentially in